Written by : Jayati Dubey
January 27, 2025
The project will be jointly funded by the central and state governments, according to M N Sridhar, Director of the Drugs Control and Controlling Authority.
A medical analysis laboratory, with an estimated investment of INR 29.67 Cr, will be established in Coimbatore to ensure the safety and efficiency of medical devices and pharmaceutical products.
According to M N Sridhar, Director of the Drugs Control and Controlling Authority, the project will be jointly funded by the central and state governments.
The upcoming facility is expected to generate employment opportunities for analysts and contribute to strengthening quality control in the healthcare sector.
Sridhar also announced that the government will introduce training programs for drug inspectors to enhance their expertise in regulatory practices and safety evaluations.
He made these remarks during an event marking the entry of European testing and inspection company IMQ Group into the Indian market.
IMQ Group, a leading European firm specializing in testing and product conformity services, has entered India through its joint venture firm, Elettra Tech Labs (IMQ India).
The company will focus on providing world-class testing services for medical devices while promoting local expertise and industry growth.
Vincenzo de Martino, President and CEO of IMQ Group, highlighted that IMQ India's operations will be led by CEO Stefano Ferretti and COO Kiran Raju Narayan.
The company plans to expand into advanced testing technologies, aligning with India’s push for innovation and sustainability.
With strong economic growth and government initiatives such as the Production Linked Incentive Scheme, India is emerging as a key global player in electronics and medical devices.
IMQ India’s entry is expected to support the country's efforts in fostering a skilled workforce and strengthening its industrial capabilities.
Stay tuned for more such updates on Digital Health News.